Nivolumab, Cabozantinib S-Malate, and Ipilimumab in Treating Patients With Recurrent Stage IV Non-small Cell Lung Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Joel W Neal
ECOG-ACRIN Cancer Research Group
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
468 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Alaska Breast Care and Surgery Llc
Anchorage, Alaska, United States
- Alaska Oncology and Hematology Llc
Anchorage, Alaska, United States
- Alaska Women'S Cancer Care
Anchorage, Alaska, United States
- Anchorage Associates in Radiation Medicine
Anchorage, Alaska, United States
- Anchorage Oncology Centre
Anchorage, Alaska, United States
- Katmai Oncology Group
Anchorage, Alaska, United States
- Providence Alaska Medical Center
Anchorage, Alaska, United States
- Chi Saint Vincent Cancer Center Hot Springs
Hot Springs, Arkansas, United States
- Nea Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro
Jonesboro, Arkansas, United States
- Pcr Oncology
Arroyo Grande, California, United States
- Providence Saint Joseph Medical Center/disney Family Cancer Center
Burbank, California, United States
- Penrose-Saint Francis Healthcare
Colorado Springs, Colorado, United States
- Rocky Mountain Cancer Centers-Penrose
Colorado Springs, Colorado, United States
- Porter Adventist Hospital
Denver, Colorado, United States
- Mercy Medical Center
Durango, Colorado, United States
- Southwest Oncology Pc
Durango, Colorado, United States
- Mountain Blue Cancer Care Center
Golden, Colorado, United States
- Rocky Mountain Cancer Centers-Lakewood
Lakewood, Colorado, United States
- Saint Anthony Hospital
Lakewood, Colorado, United States
- Littleton Adventist Hospital
Littleton, Colorado, United States
- Longmont United Hospital
Longmont, Colorado, United States
- Rocky Mountain Cancer Centers-Longmont
Longmont, Colorado, United States
- Parker Adventist Hospital
Parker, Colorado, United States
- Rocky Mountain Cancer Centers-Parker
Parker, Colorado, United States
- Rocky Mountain Cancer Centers - Pueblo
Pueblo, Colorado, United States
- Saint Mary Corwin Medical Center
Pueblo, Colorado, United States
- Rocky Mountain Cancer Centers-Thornton
Thornton, Colorado, United States
- Broward Health Medical Center
Fort Lauderdale, Florida, United States
- University Cancer and Blood Center Llc
Athens, Georgia, United States
- Dekalb Medical Center
Decatur, Georgia, United States
- Saint Alphonsus Cancer Care Center-Boise
Boise, Idaho, United States
- Saint Luke'S Cancer Institute - Boise
Boise, Idaho, United States
- Saint Alphonsus Cancer Care Center-Caldwell
Caldwell, Idaho, United States
- Kootenai Health - Coeur D'Alene
Coeur d'Alene, Idaho, United States
- Walter Knox Memorial Hospital
Emmett, Idaho, United States
- Saint Luke'S Cancer Institute - Fruitland
Fruitland, Idaho, United States
- Idaho Urologic Institute-Meridian
Meridian, Idaho, United States
- Saint Luke'S Cancer Institute - Meridian
Meridian, Idaho, United States
- Saint Alphonsus Medical Center-Nampa
Nampa, Idaho, United States
- Saint Luke'S Cancer Institute - Nampa
Nampa, Idaho, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 7 May 2018
- Primary completion
- 9 May 2022
- Completion
- 21 Dec 2022
- Last update posted
- 17 Oct 2023
- Registered enrollment
- 3
- Registry id
- NCT03468985
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.